These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 23939463)

  • 21. Narcolepsy and the hypocretins.
    Wurtman RJ
    Metabolism; 2006 Oct; 55(10 Suppl 2):S36-9. PubMed ID: 16979425
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increased cerebrospinal fluid levels of nerve cell biomarkers in narcolepsy with cataplexy.
    Heier MS; Skinningsrud A; Paus E; Gautvik KM
    Sleep Med; 2014 Jun; 15(6):614-8. PubMed ID: 24784789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Voxel-based morphometry in hypocretin-deficient narcolepsy.
    Overeem S; Steens SC; Good CD; Ferrari MD; Mignot E; Frackowiak RS; van Buchem MA; Lammers GJ
    Sleep; 2003 Feb; 26(1):44-6. PubMed ID: 12627731
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Increased immune complexes of hypocretin autoantibodies in narcolepsy.
    Deloumeau A; Bayard S; Coquerel Q; Déchelotte P; Bole-Feysot C; Carlander B; Cochen De Cock V; Fetissov SO; Dauvilliers Y
    PLoS One; 2010 Oct; 5(10):e13320. PubMed ID: 20967199
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Advances in narcolepsy.
    Cao M
    Med Clin North Am; 2010 May; 94(3):541-55. PubMed ID: 20451031
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Pathogenesis of narcolepsy: from HLA association to hypocretin deficiency].
    Klein G; Burghaus L; Diederich N
    Fortschr Neurol Psychiatr; 2012 Nov; 80(11):627-34. PubMed ID: 22696207
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical screening for autoantibodies against lateral hypothalamic neurons in human narcolepsy.
    Overeem S; Verschuuren JJ; Fronczek R; Schreurs L; den Hertog H; Hegeman-Kleinn IM; van Duinen SG; Unmehopa UA; Swaab DF; Lammers GJ
    J Neuroimmunol; 2006 May; 174(1-2):187-91. PubMed ID: 16563524
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Narcolepsy caused by acute disseminated encephalomyelitis.
    Gledhill RF; Bartel PR; Yoshida Y; Nishino S; Scammell TE
    Arch Neurol; 2004 May; 61(5):758-60. PubMed ID: 15148155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunopathology of autoantibody-associated encephalitides: clues for pathogenesis.
    Bien CG; Vincent A; Barnett MH; Becker AJ; Blümcke I; Graus F; Jellinger KA; Reuss DE; Ribalta T; Schlegel J; Sutton I; Lassmann H; Bauer J
    Brain; 2012 May; 135(Pt 5):1622-38. PubMed ID: 22539258
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Neurodegenerative, autoimmune and genetic processes of human and animal narcolepsy].
    Dauvilliers Y
    Rev Neurol (Paris); 2003 Nov; 159(11 Suppl):6S83-7. PubMed ID: 14646805
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypocretin-1 CSF levels in anti-Ma2 associated encephalitis.
    Overeem S; Dalmau J; Bataller L; Nishino S; Mignot E; Verschuuren J; Lammers GJ
    Neurology; 2004 Jan; 62(1):138-40. PubMed ID: 14718718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Orexin peptides prevent cataplexy and improve wakefulness in an orexin neuron-ablated model of narcolepsy in mice.
    Mieda M; Willie JT; Hara J; Sinton CM; Sakurai T; Yanagisawa M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4649-54. PubMed ID: 15070772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Elevated glial fibrillary acidic protein levels in the cerebrospinal fluid of patients with narcolepsy.
    Feneberg E; Steinacker P; Lehnert S; Böhm B; Mayer G; Otto M
    Sleep Med; 2013 Jul; 14(7):692-4. PubMed ID: 23746601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypocretins (orexins): clinical impact of the discovery of a neurotransmitter.
    Baumann CR; Bassetti CL
    Sleep Med Rev; 2005 Aug; 9(4):253-68. PubMed ID: 15979356
    [TBL] [Abstract][Full Text] [Related]  

  • 36. IGFBP3 colocalizes with and regulates hypocretin (orexin).
    Honda M; Eriksson KS; Zhang S; Tanaka S; Lin L; Salehi A; Hesla PE; Maehlen J; Gaus SE; Yanagisawa M; Sakurai T; Taheri S; Tsuchiya K; Honda Y; Mignot E
    PLoS One; 2009; 4(1):e4254. PubMed ID: 19158946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypocretin/orexin and sleep: implications for the pathophysiology and diagnosis of narcolepsy.
    Overeem S; Scammell TE; Lammers GJ
    Curr Opin Neurol; 2002 Dec; 15(6):739-45. PubMed ID: 12447114
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A patient with both narcolepsy and multiple sclerosis in association with Pandemrix vaccination.
    Vrethem M; Malmgren K; Lindh J
    J Neurol Sci; 2012 Oct; 321(1-2):89-91. PubMed ID: 22841884
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The pathophysiologic basis of secondary narcolepsy and hypersomnia.
    Kanbayashi T; Sagawa Y; Takemura F; Ito SU; Tsutsui K; Hishikawa Y; Nishino S
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):235-41. PubMed ID: 21298561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.